Cargando…

Effects of enamel matrix derivative and transforming growth factor-β1 on human osteoblastic cells

BACKGROUND: Extracellular matrix proteins are key factors that influence the regenerative capacity of tissues. The objective of the present study was to evaluate the effects of enamel matrix derivative (EMD), TGF-β1, and the combination of both factors (EMD+TGF-β1) on human osteoblastic cell culture...

Descripción completa

Detalles Bibliográficos
Autores principales: Palioto, Daniela B, Rodrigues, Thaisângela L, Marchesan, Julie T, Beloti, Márcio M, de Oliveira, Paulo T, Rosa, Adalberto L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162535/
https://www.ncbi.nlm.nih.gov/pubmed/21767401
http://dx.doi.org/10.1186/1746-160X-7-13
_version_ 1782210823805992960
author Palioto, Daniela B
Rodrigues, Thaisângela L
Marchesan, Julie T
Beloti, Márcio M
de Oliveira, Paulo T
Rosa, Adalberto L
author_facet Palioto, Daniela B
Rodrigues, Thaisângela L
Marchesan, Julie T
Beloti, Márcio M
de Oliveira, Paulo T
Rosa, Adalberto L
author_sort Palioto, Daniela B
collection PubMed
description BACKGROUND: Extracellular matrix proteins are key factors that influence the regenerative capacity of tissues. The objective of the present study was to evaluate the effects of enamel matrix derivative (EMD), TGF-β1, and the combination of both factors (EMD+TGF-β1) on human osteoblastic cell cultures. METHODS: Cells were obtained from alveolar bone of three adult patients using enzymatic digestion. Effects of EMD, TGF-β1, or a combination of both were analyzed on cell proliferation, bone sialoprotein (BSP), osteopontin (OPN) and alkaline phosphatase (ALP) immunodetection, total protein synthesis, ALP activity and bone-like nodule formation. RESULTS: All treatments significantly increased cell proliferation compared to the control group at 24 h and 4 days. At day 7, EMD group showed higher cell proliferation compared to TGF-β1, EMD + TGF-β1 and the control group. OPN was detected in the majority of the cells for all groups, whereas fluorescence intensities for ALP labeling were greater in the control than in treated groups; BSP was not detected in all groups. All treatments decreased ALP levels at 7 and 14 days and bone-like nodule formation at 21 days compared to the control group. CONCLUSIONS: The exposure of human osteoblastic cells to EMD, TGF-β1 and the combination of factors in vitro supports the development of a less differentiated phenotype, with enhanced proliferative activity and total cell number, and reduced ALP activity levels and matrix mineralization.
format Online
Article
Text
id pubmed-3162535
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31625352011-08-27 Effects of enamel matrix derivative and transforming growth factor-β1 on human osteoblastic cells Palioto, Daniela B Rodrigues, Thaisângela L Marchesan, Julie T Beloti, Márcio M de Oliveira, Paulo T Rosa, Adalberto L Head Face Med Research BACKGROUND: Extracellular matrix proteins are key factors that influence the regenerative capacity of tissues. The objective of the present study was to evaluate the effects of enamel matrix derivative (EMD), TGF-β1, and the combination of both factors (EMD+TGF-β1) on human osteoblastic cell cultures. METHODS: Cells were obtained from alveolar bone of three adult patients using enzymatic digestion. Effects of EMD, TGF-β1, or a combination of both were analyzed on cell proliferation, bone sialoprotein (BSP), osteopontin (OPN) and alkaline phosphatase (ALP) immunodetection, total protein synthesis, ALP activity and bone-like nodule formation. RESULTS: All treatments significantly increased cell proliferation compared to the control group at 24 h and 4 days. At day 7, EMD group showed higher cell proliferation compared to TGF-β1, EMD + TGF-β1 and the control group. OPN was detected in the majority of the cells for all groups, whereas fluorescence intensities for ALP labeling were greater in the control than in treated groups; BSP was not detected in all groups. All treatments decreased ALP levels at 7 and 14 days and bone-like nodule formation at 21 days compared to the control group. CONCLUSIONS: The exposure of human osteoblastic cells to EMD, TGF-β1 and the combination of factors in vitro supports the development of a less differentiated phenotype, with enhanced proliferative activity and total cell number, and reduced ALP activity levels and matrix mineralization. BioMed Central 2011-07-18 /pmc/articles/PMC3162535/ /pubmed/21767401 http://dx.doi.org/10.1186/1746-160X-7-13 Text en Copyright ©2011 Palioto et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Palioto, Daniela B
Rodrigues, Thaisângela L
Marchesan, Julie T
Beloti, Márcio M
de Oliveira, Paulo T
Rosa, Adalberto L
Effects of enamel matrix derivative and transforming growth factor-β1 on human osteoblastic cells
title Effects of enamel matrix derivative and transforming growth factor-β1 on human osteoblastic cells
title_full Effects of enamel matrix derivative and transforming growth factor-β1 on human osteoblastic cells
title_fullStr Effects of enamel matrix derivative and transforming growth factor-β1 on human osteoblastic cells
title_full_unstemmed Effects of enamel matrix derivative and transforming growth factor-β1 on human osteoblastic cells
title_short Effects of enamel matrix derivative and transforming growth factor-β1 on human osteoblastic cells
title_sort effects of enamel matrix derivative and transforming growth factor-β1 on human osteoblastic cells
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162535/
https://www.ncbi.nlm.nih.gov/pubmed/21767401
http://dx.doi.org/10.1186/1746-160X-7-13
work_keys_str_mv AT paliotodanielab effectsofenamelmatrixderivativeandtransforminggrowthfactorb1onhumanosteoblasticcells
AT rodriguesthaisangelal effectsofenamelmatrixderivativeandtransforminggrowthfactorb1onhumanosteoblasticcells
AT marchesanjuliet effectsofenamelmatrixderivativeandtransforminggrowthfactorb1onhumanosteoblasticcells
AT belotimarciom effectsofenamelmatrixderivativeandtransforminggrowthfactorb1onhumanosteoblasticcells
AT deoliveirapaulot effectsofenamelmatrixderivativeandtransforminggrowthfactorb1onhumanosteoblasticcells
AT rosaadalbertol effectsofenamelmatrixderivativeandtransforminggrowthfactorb1onhumanosteoblasticcells